Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07406087 · ClinicalTrials.gov registry record · NA

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

A NA study, sponsored by Kaiser Permanente.

Recruiting
Registry status
NA
Development phase
25
Enrollment target

NCT07406087 is a NA study that is actively recruiting participants, run by Kaiser Permanente. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07406087, a NA study, is actively recruiting participants, sponsored by Kaiser Permanente.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

The investigators propose to: 1) Adapt an evidence-based cancer-focused patient navigation (PN) program for the Adolescent and Young Adult (AYA) cancer survivor population; and 2) Plan and conduct an effectiveness-implementation trial of this program within Kaiser Permanente Southern California (KPSC). PLEASE NOTE: This study is awarded in two phases. The UG3 phase has been awarded for the first two years; upon successful completion of this phase by meeting pre-defined milestones, the National Cancer Institute (NCI) will provide funding for the second phase of the study (Years 3-6), which will allow our team to conduct a trial to determine the effectiveness of the implementation of the adapted PN program for the AYA cancer survivor population. This application is focused on the initial UG3 phase and will update the protocol for the UH3 trial upon successful completion of the UG3 milestones and receipt of the UH3 award. The primary objectives in the UG3 phase of the study are to adapt and tailor an existing PN program to meet the needs of AYA cancer survivors and the local clinical context via (a) interviews with key stakeholders (patients, clinicians, administrators) and (b) guidance from our AYA Primary Care Survivorship Council. The investigators will conduct a pilot study of the adapted PN program and refine the program to enhance acceptability to patients and clinicians, enhance feasibility and effectiveness, and develop and pilot evaluation tools and methods prior to the start of the UH3 phase of the trial, which will be a larger trial. Objectives will be updated for the UH3 phase once awarded.

Interventions

  • BEHAVIORAL Adapted patient navigation program targeting adolescent and young adult cancer survivors

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2026-03-15
Est. Completion 2027-08
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT07406087

The ClinicalTrials.gov registry entry for NCT07406087 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Adapted patient navigation program targeting adolescent and young adult cancer survivors is the first listed.

NCT07406087 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07406087 about?

NCT07406087 is a clinical study titled "Navigation Intervention for Adolescent and Young Adult Cancer Survivors". The investigators propose to: 1) Adapt an evidence-based cancer-focused patient navigation (PN) program for the Adolescent and Young Adult (AYA) cancer survivor population; and 2) Plan and conduct an effectiveness-implementation trial of this program within Kaiser Permanente Southern California (KPS...

What is the current status of trial NCT07406087?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-03-15. Estimated completion is 2027-08.

What interventions are being tested in trial NCT07406087?

The interventions under investigation include: Adapted patient navigation program targeting adolescent and young adult cancer survivors (BEHAVIORAL).

Who is sponsoring clinical trial NCT07406087?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.